BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18571348)

  • 1. The application of artificial neural networks in the prediction of microemulsion phase boundaries in PEG-8 caprylic/capric glycerides based systems.
    Djekic L; Ibric S; Primorac M
    Int J Pharm; 2008 Sep; 361(1-2):41-6. PubMed ID: 18571348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of cosurfactants and oils on the formation of pharmaceutical microemulsions based on PEG-8 caprylic/capric glycerides.
    Djekic L; Primorac M
    Int J Pharm; 2008 Mar; 352(1-2):231-9. PubMed ID: 18068919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of caprylocaproyl macrogolglycerides based microemulsion drug delivery vehicles for an amphiphilic drug.
    Djordjevic L; Primorac M; Stupar M; Krajisnik D
    Int J Pharm; 2004 Mar; 271(1-2):11-9. PubMed ID: 15129969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro release of diclofenac diethylamine from caprylocaproyl macrogolglycerides based microemulsions.
    Djordjevic L; Primorac M; Stupar M
    Int J Pharm; 2005 May; 296(1-2):73-9. PubMed ID: 15885457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and evaluation of fexofenadine microemulsions for intranasal delivery.
    Piao HM; Balakrishnan P; Cho HJ; Kim H; Kim YS; Chung SJ; Shim CK; Kim DD
    Int J Pharm; 2010 Aug; 395(1-2):309-16. PubMed ID: 20635476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation of parenteral microemulsion containing itraconazole.
    Rhee YS; Park CW; Nam TY; Shin YS; Chi SC; Park ES
    Arch Pharm Res; 2007 Jan; 30(1):114-23. PubMed ID: 17328251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative evaluation of mono-, di- and triglyceride of medium chain fatty acids by lipid/surfactant/water phase diagram, solubility determination and dispersion testing for application in pharmaceutical dosage form development.
    Prajapati HN; Dalrymple DM; Serajuddin AT
    Pharm Res; 2012 Jan; 29(1):285-305. PubMed ID: 21861203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, evaluation, and NMR characterization of vinpocetine microemulsion for transdermal delivery.
    Hua L; Weisan P; Jiayu L; Ying Z
    Drug Dev Ind Pharm; 2004 Jul; 30(6):657-66. PubMed ID: 15285339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cremophor RH40-PEG 400 microemulsions as transdermal drug delivery carrier for ketoprofen.
    Ngawhirunpat T; Worachun N; Opanasopit P; Rojanarata T; Panomsuk S
    Pharm Dev Technol; 2013; 18(4):798-803. PubMed ID: 22023398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical characterization and evaluation of a microemulsion system for antimicrobial activity of glycerol monolaurate.
    Fu X; Feng F; Huang B
    Int J Pharm; 2006 Sep; 321(1-2):171-5. PubMed ID: 16797893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of microemulsion microstructures and their relationship to transdermal permeation of model drugs: ketoprofen, lidocaine, and caffeine.
    Zhang J; Michniak-Kohn B
    Int J Pharm; 2011 Dec; 421(1):34-44. PubMed ID: 21959104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and physicochemical characterization of microemulsion system using isopropyl myristate, medium-chain glyceride, polysorbate 80 and water.
    Subramanian N; Ghosal SK; Acharya A; Moulik SP
    Chem Pharm Bull (Tokyo); 2005 Dec; 53(12):1530-5. PubMed ID: 16327183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the potential of N-methyl pyrrolidone as a cosurfactant in the microemulsion systems.
    Bachhav YG; Date AA; Patravale VB
    Int J Pharm; 2006 Dec; 326(1-2):186-9. PubMed ID: 16949777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating effect of microemulsion components: In vitro permeation of ketoconazole.
    Patel MR; Patel RB; Parikh JR; Solanki AB; Patel BG
    Pharm Dev Technol; 2011 Jun; 16(3):250-8. PubMed ID: 20146553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation design of microemulsion for dermal delivery of penciclovir.
    Zhu W; Yu A; Wang W; Dong R; Wu J; Zhai G
    Int J Pharm; 2008 Aug; 360(1-2):184-90. PubMed ID: 18541394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Solubilization of O/W microemulsion for volatile oil from Houttuynia Cordra].
    Yi H; Gao J; Yang H
    Zhongguo Zhong Yao Za Zhi; 2010 Jan; 35(1):49-52. PubMed ID: 20349715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of genetic algorithms and artificial neural networks in predicting the phase behavior of colloidal delivery systems.
    Agatonovic-Kustrin S; Alany RG
    Pharm Res; 2001 Jul; 18(7):1049-55. PubMed ID: 11496944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced bioavailability of lacidipine via microemulsion based transdermal gels: formulation optimization, ex vivo and in vivo characterization.
    Gannu R; Palem CR; Yamsani VV; Yamsani SK; Yamsani MR
    Int J Pharm; 2010 Mar; 388(1-2):231-41. PubMed ID: 20060457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical characterization of rutaecarpine-loaded microemulsion system.
    Choi HG; Park BJ; Kim JO; Park YJ; Kim JK; Yoo BK; Rhee JD; Jahng Y; Yong CS
    Drug Dev Ind Pharm; 2005 Aug; 31(7):639-43. PubMed ID: 16207611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal delivery of hydrocortisone from eucalyptus oil microemulsion: effects of cosurfactants.
    El Maghraby GM
    Int J Pharm; 2008 May; 355(1-2):285-92. PubMed ID: 18243604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.